Skip to content
Research Article Open access CC BY 4.0

Influence of Covid-19 Pandemic on Safe and Timely Delivery of Systemic Anti-Cancer Therapy, Dubai Hospital Experience

Muhammad Farooq Latif, Syed Hammad Tirmazy, Dalia Mahmoud El-Shourbagy

Journal of Cancer and Tumor International · pp. 81–87 · Published 24 Dec 2022

10.9734/jcti/2022/v12i4223

Abstract

Aims: To analyze the effect of COVID-19 pandemic on timely delivery of systemic anti-cancer treatment including chemotherapy, biological therapy and immunotherapy and assess complication rate. Place and Duration of Study: Department of Oncology, Dubai Hospital, Dubai, UAE from January 2020 to July 2020. Methods: This is a retrospective review of electronic medical records and infusion Centre log of the number of chemotherapy sessions administered in the infusion therapy Centre, Dubai hospital from January 2020 to July 2020. Data on treatment delays, interruptions or discontinuations, and adverse events such as febrile neutropenia were collected and analysed. Results: A total of 1553 systemic treatment sessions were recorded between January 2020 to July 2020 with an average of 222 treatment sessions per month. Physician recorded delays were observed in ninety (5.79%) treatment sessions. The average treatment delay was 7 (2-13) days. Delays were frequently caused by the overall treatment course and disease-related factors (toxicities, disease progression). The highest number of treatment delays (n=23,10.2%) were recorded in April, at the peak of the Covid-19 pandemic, most likely because of the implementation of extreme precautionary measures. There were no interruptions or discontinuations in treatment. Fourteen (<1%) patients developed febrile neutropenia. With treatment, all of them recovered fully. No significant change in systemic treatment related complications were observed during the pandemic. Conclusion: This study found no evidence of an appreciable rise in the number of complications or delays in systemic anticancer treatment during the COVID-19 pandemic. This experience indicates that systemic chemotherapy may be delivered successfully during a pandemic with infection control and safety precautions. However, more research with a larger sample size is needed for more accurate advice in this case.

COVID-19 infection pandemic systemic anticancer therapy neutropenia

References (16)

  1. 1 Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China [DOI]
  2. 2 Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China [DOI]
  3. 3 COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study [DOI]
  4. 4 Management of febrile neutropaenia: ESMO Clinical Practice Guidelines [DOI]
  5. 5 Coronavirus Disease 2019 (COVID-19) Pandemic [DOI]
  6. 6 Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review [DOI]
  7. 7 Risk of COVID-19 for patients with cancer [DOI]
  8. 8 Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors [DOI]
  9. 9 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients [DOI]
  10. 10 Colony-Stimulating Factors for the Management of Neutropenia in Cancer Patients [DOI]
  11. 11 The financial impact of COVID-19 on a surgical department: The effects of surgical shutdowns and the impact on a health system [DOI]
  12. 12 Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic [DOI]
  13. 13 Delivery of systemic anti-cancer therapy during the COVID-19 pandemic [DOI]
  14. 14 The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer Centre [DOI]
  15. 15 Coronavirus disease (COVID-19) pandemic.
  16. 16 Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multi-Center Study During the COVID-19 Outbreak [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

32

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.